DUBLIN–(BUSINESS WIRE)–The “Hepatitis B Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033” report has been added to ResearchAndMarkets.com’s offering.
The global Hepatitis B Tests market is on a trajectory of steady growth, driven by increasing awareness about Hepatitis B, routine screening programs, and the implementation of universal vaccination strategies.
Despite the availability of an effective vaccine since 1982, Hepatitis B remains a significant public health concern worldwide. The World Health Organization (WHO) recommends universal hepatitis B vaccination for all infants, leading to its widespread adoption in numerous countries.
Key Factors Driving Market Growth:
- Universal Vaccination: Implementation of universal vaccination programs in many countries has significantly reduced the incidence of Hepatitis B, driving the demand for testing during pregnancy and for high-risk individuals.
- Pregnancy Screening: Routine screening of pregnant women for Hepatitis B is standard practice in most countries, reducing the risk of transmission from mother to baby.
- Donor Screening: Hepatitis B tests are essential for screening donors of human cells, tissues, and cellular and tissue-based products (HCT/P).
- Diagnostic and Monitoring: Hepatitis B tests are crucial for diagnosing suspected infections, monitoring HBV-positive patients, and assessing the effectiveness of treatment.
Market Segmentation:
The Hepatitis B Tests market includes various segments, such as Hepatitis B Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests, Hepatitis B Nucleic Acid Amplification Tests (NAATs), and Multi-parameter HIV, Hepatitis B, and Hepatitis C NAATs.
Key Market Players:
The market features several key players, including:
- Abbott Laboratories
- Bio-Rad Laboratories Inc
- Hologic Inc
- Quidelortho Corp
- Oswaldo Cruz Foundation
- Grifols SA
- F. Hoffmann-La Roche Ltd
- Siemens AG
- Qiagen NV
- biomerieux SA
- DiaSorin SpA
Market Model Insights:
- The market has exhibited sequential growth and is expected to continue to grow steadily.
- Annualized total Hepatitis B Tests market revenue and market outlooks are provided from 2015-2033.
- The model offers market level data on units, average selling prices, and market values.
- Qualitative market-specific information is available with global trends further broken down into regional trends.
- SWOT analysis for the Hepatitis B Tests market and competitive dynamics insights are also provided.
Scope:
This Market Model provides essential insights into the Hepatitis B Tests market, making it a valuable resource for:
- CMO executives involved in strategic planning and investment decisions.
- Sourcing and procurement executives seeking a deeper understanding of the supply base.
- Private equity investors looking to identify and value potential investment targets.
Reasons to Buy:
The model enables you to:
- Understand the impact of COVID-19 on the Hepatitis B Tests market.
- Develop in-licensing and out-licensing strategies by reviewing pipeline products and technologies.
- Formulate business strategies by identifying key trends, products, and technologies shaping the market.
- Drive revenues by identifying growth opportunities and competitive advantages.
- Organize sales and marketing efforts by identifying market categories and segments with the highest potential.
For more information about this report visit https://www.researchandmarkets.com/r/inw2eu
Source: GlobalData
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
